Herpes Zoster (Shingles): A Guide to Symptoms, Recovery & Supportive Laser Therapy

Educational information for Ottawa and surrounding communities

Herpes zoster, commonly known as shingles, is a painful viral condition that affects thousands of Canadians each year—particularly adults over 50 or those with weakened immune systems.

At The Ageless Skin Co., medical-grade laser therapy is used as a supportive, non-invasive modality to help manage inflammation, promote tissue repair, and assist in recovery alongside appropriate medical care.

What Is Shingles?

Shingles is caused by reactivation of the varicella-zoster virus (VZV)—the same virus responsible for chickenpox.

After a person recovers from chickenpox, the virus remains dormant in sensory nerve ganglia. Years later, it can reactivate, traveling along nerve pathways to the skin.

Common Symptoms

Shingles typically presents as:

• Burning, tingling, or stabbing pain (often before the rash appears)

• A unilateral rash following a dermatome (nerve distribution)

• Fluid-filled blisters that crust over within 7–10 days

• Sensitivity to touch

• Fatigue or mild fever

One of the most significant complications is postherpetic neuralgia (PHN)—persistent nerve pain that can last months or even years after the rash resolves.

Why Early Treatment Matters

Medical guidelines recommend early antiviral therapy (e.g., within 72 hours of rash onset) to:

• Reduce viral replication

• Shorten duration of symptoms

• Lower the risk of complications like PHN

Prompt medical assessment is essential for anyone who suspects shingles.

The Role of Inflammation and Nerve Damage

Shingles affects both the skin and nervous system.

During reactivation, the virus triggers:

• Neuroinflammation within affected nerves

• Damage to sensory nerve fibers

• Release of inflammatory mediators

• Increased pain signaling

This combination contributes to both acute pain and long-term nerve sensitivity.

How Laser Therapy May Support Recovery

Low-level laser therapy (LLLT), or photobiomodulation, uses red and near-infrared light to influence cellular activity and reduce inflammation.

Research suggests several mechanisms relevant to shingles:

✔ Reduction of Inflammation

Photobiomodulation has been shown to decrease pro-inflammatory cytokines, helping calm the inflammatory response in affected tissues.

✔ Support for Nerve Repair

Studies indicate PBM may enhance nerve regeneration and improve functional recovery following nerve injury.

✔ Pain Modulation

Laser therapy can influence peripheral nerve conduction and reduce pain signaling, which may help decrease discomfort during both acute and postherpetic phases.

✔ Improved Tissue Healing

By increasing ATP production and circulation, PBM supports skin repair and recovery of damaged tissue.

What the Research Shows

Emerging clinical evidence suggests:

• Reduced pain intensity and duration in patients receiving photobiomodulation

• Faster healing of skin lesions

• Potential reduction in incidence or severity of postherpetic neuralgia when used early

While more large-scale studies are ongoing, current findings support PBM as a promising adjunct therapy in herpes zoster management.

Who May Benefit?

Laser therapy may be considered for individuals who:

• Are experiencing active shingles (with physician approval)

• Have lingering nerve pain (postherpetic neuralgia)

• Prefer non-invasive, drug-free supportive options

• Are seeking to complement medical treatment

  
  

A Responsible, Medical-First Approach

Shingles is a medical condition that requires proper diagnosis and treatment.

Laser therapy should:

• Be used in conjunction with medical care, not as a replacement

• Only be applied when appropriate and safe for the stage of the condition

• Be part of a broader recovery plan

Anyone experiencing symptoms of shingles should consult a healthcare provider promptly.

Shingles in Ottawa: Why Awareness Matters

In communities like Ottawa and surrounding areas, access to timely care and supportive therapies can make a meaningful difference in recovery outcomes—particularly for aging populations or individuals managing chronic stress and immune challenges.

Education and early intervention are key to reducing complications and improving quality of life.

Scientific References

Dworkin, R. H., Johnson, R. W., Breuer, J., et al. (2007). Recommendations for the management of herpes zoster. Clinical Infectious Diseases, 44(Suppl 1), S1–S26.

Cohen, J. I. (2013). Herpes zoster. New England Journal of Medicine, 369(3), 255–263.

Oaklander, A. L., & Fields, H. L. (2009). The pathogenesis of herpes zoster and postherpetic neuralgia. Pain, 142(1–2), 1–5.

Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337–361.

de Freitas, L. F., & Hamblin, M. R. (2016). Proposed mechanisms of photobiomodulation in nerve repair. Neural Regeneration Research, 11(6), 839–848.

Alayat, M. S. M., et al. (2014). Effect of low-level laser therapy on pain and quality of life in patients with postherpetic neuralgia. Lasers in Medical Science, 29(5), 1665–1670.